Skip to content

Skull repair using adult stem cells and a dissolving scaffold

Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials in adults with a cranial defect.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000394145
Enrollment
1
Registered
2019-03-12
Start date
2019-02-06
Completion date
2021-02-06
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Brief Summary Cranial reconstruction using mesenchymal stromal cells and resorbable biomaterials, will result in the patient producing their own bone to fill the void which will reduce the risk of infection and resorption, lead to a better cosmetic result and obviate any long term consequence of having a synthetic material in vivo. Introduction: There are several reasons that parts of the skull may need to be removed: - After trauma to relieve brain swelling - During brain surgery (for brain cancer) - After trauma where the bone is so badly fractured/fragmented it needs to be removed. In all but the last case the bone flap is temporarily stored in a freezer and once the brain swelling has subsided it is reinserted. This procedure is called "autologous cranioplasty"; autologous, because it originally came from the patient and cranioplasty, referring to the repair. Although this is a straightforward procedure, there are a number of complications including infection and bone resorption that can occur. This study: Stromal cells have a proven ability to aid in bony healing. Furthermore stromal cells on a ceramic framework encased in a plastic scaffold have been shown in a small clinical trial to lead to healing of skull defects. In the present study, it is proposed to add stromal cells, either autologous or allogeneic, to a resorbable ceramic material and insert into the skull. The ceramic is designed to dissolve away over time as the body's own blood vessels and cells populate the construct and create the patient's new bone. It has been proven that without the encouragement of the cells and temporary scaffold materials, a hole in the skull will not heal. Given the incidence of bone resorption/infection and metal plate infection using traditional methods, it would seem prudent to provide a construct that will allow controlled replacement with the patient's own bone, thus negating any adverse long-term complications with synthetic materials that remain for life.

Interventions

The intervention is cranioplasty. a) any physical or informational materials used, Patient Information Sheets (PIS) will be provided to each patient enrolled in the trial. b) each of the procedures, activities, and/or processes used, 1. Patient consent 2. Stem Cell Collection • Blood Test • Bone Marrow Aspirate • MSC processing • Delivery of Intervention by Haematologist 3. Insertion of cranioplasty c) who will deliver the intervention, Consultant Haematologist with regard to stem cell

The intervention is cranioplasty. a) any physical or informational materials used, Patient Information Sheets (PIS) will be provided to each patient enrolled in the trial. b) each of the procedures, activities, and/or processes used, 1. Patient consent 2. Stem Cell Collection • Blood Test • Bone Marrow Aspirate • MSC processing • Delivery of Intervention by Haematologist 3. Insertion of cranioplasty c) who will deliver the intervention, Consultant Haematologist with regard to stem cells Consultant Neurosurgeon with regard to cranioplasty insertion d) the mode of delivery, Face to face and in theatre e) the number of times the intervention will be delivered and over what period of time, Once at time of theatre. f) the location/setting where the intervention occurs. Major Public Hospital

Sponsors

Stephen Honeybul
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- All adult patients (age > 18 years) who have a cranial defect that requires reconstruction with a defect size of less than 110 x 180mm.

Exclusion criteria

- Patients who have had a previous cranial infection - Positive bone marrow aspirate on testing for microcontamination - Positive testing for infectious disease - Patients who have neurocognitive difficulties and are as such unable to provide informed consent - Patients with an ongoing intracranial infection following craniotomy - Pregnant or breastfeeding females

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026